Literature DB >> 19440844

Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength.

Ashwini R Madgulkar1, Mangesh R Bhalekar, Rahul R Padalkar.   

Abstract

The purpose of this work was to develop novel taste masked mouth-dissolving tablets of tramadol that overcomes principle drawback of such formulation which is inadequate mechanical strength. Tramadol is an opioid analgesic used for the treatment of moderate to severe pain. Mouth-dissolving tablets offer substantial advantages like rapid onset of action, beneficial for patients having difficulties in swallowing and in conditions where access to water is difficult. The crucial aspect in the formulation of mouth-dissolving tablets is to mask the bitter taste and to minimize the disintegration time while maintaining a good mechanical strength of the tablet. Mouth-dissolving tablets of tramadol are not yet reported in the literature because of its extreme bitter taste. In this work, the bitter taste of Tramadol HCl was masked by forming a complex with an ion exchange resin Tulsion335. The novel combination of a superdisintegrant and a binder that melts near the body temperature was used to formulate mechanically strong tablets that showed fast disintegration. A 3(2) full factorial design and statistical models were applied to optimize the effect of two factors, i.e., superdisintegrant (crospovidone) and a mouth-melting binder (Gelucire 39/01). It was observed that the responses, i.e., disintegration time and percent friability were affected by both the factors. The statistical models were validated and can be successfully used to prepare optimized taste masked mouth-dissolving tablets of Tramadol HCl with adequate mechanical strength and rapid disintegration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440844      PMCID: PMC2690800          DOI: 10.1208/s12249-009-9237-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  10 in total

1.  Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.

Authors:  Yutaka Morita; Yuki Tsushima; Masanobu Yasui; Ryoji Termoz; Junko Ajioka; Kozo Takayama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-09       Impact factor: 1.645

2.  A new method for disintegration studies of rapid disintegrating tablet.

Authors:  Ryuichi Narazaki; Tsutomu Harada; Norishige Takami; Yoshiteru Kato; Takayuki Ohwaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-06       Impact factor: 1.645

3.  A novel method for predicting disintegration time in the mouth of rapidly disintegrating tablet by compaction analysis using TabAll.

Authors:  Yusuke Shibata; Yoshihisa Yamamoto; Makiko Fujii; Masuo Kondoh; Yoshiteru Watanabe
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-11       Impact factor: 1.645

4.  Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets.

Authors:  S Borodkin; D P Sundberg
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

5.  Molecular properties of ciprofloxacin-Indion 234 complexes.

Authors:  Sambhaji Pisal; Rana Zainnuddin; Pradeep Nalawade; Kakasaheb Mahadik; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2004-09-22       Impact factor: 3.246

6.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.

Authors:  Mukesh Gohel; Madhabhai Patel; Avani Amin; Ruchi Agrawal; Rikita Dave; Nehal Bariya
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

Review 7.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 8.  Taste masking technologies in oral pharmaceuticals: recent developments and approaches.

Authors:  Harmik Sohi; Yasmin Sultana; Roop K Khar
Journal:  Drug Dev Ind Pharm       Date:  2004-05       Impact factor: 3.225

9.  Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters.

Authors:  Bhupinder Singh; Naveen Ahuja
Journal:  Drug Dev Ind Pharm       Date:  2002-04       Impact factor: 3.225

10.  Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.

Authors:  Shagufta Khan; Prashant Kataria; Premchand Nakhat; Pramod Yeole
Journal:  AAPS PharmSciTech       Date:  2007-06-22       Impact factor: 3.246

  10 in total
  6 in total

Review 1.  Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.

Authors:  John N Coupland; John E Hayes
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

2.  Drug resinates an attractive approach of solubility enhancement of atorvastatin calcium.

Authors:  V V Kulthe; P D Chaudhari
Journal:  Indian J Pharm Sci       Date:  2013-09       Impact factor: 0.975

3.  Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study.

Authors:  Manu Sharma; Ranju Soni
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

Review 4.  Developments in Taste-Masking Techniques for Traditional Chinese Medicines.

Authors:  Xiao Zheng; Fei Wu; Yanlong Hong; Lan Shen; Xiao Lin; Yi Feng
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

5.  Development of Lipid-Based Gastroretentive Delivery System for Gentian Extract by Double Emulsion-Melt Dispersion Technique.

Authors:  Jelena Mudrić; Katarina Šavikin; Ljiljana Đekić; Stefan Pavlović; Ivana Kurćubić; Svetlana Ibrić; Jelena Đuriš
Journal:  Pharmaceutics       Date:  2021-12-06       Impact factor: 6.321

6.  Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method.

Authors:  Saleh Abd El Rasoul; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2017-05-20       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.